Skip to content

Effect of Ultrasound-Guided Stellate Ganglion Block on Perioperative Inflammatory Factors in Elderly Patients Undergoing Open Reduction and Intramedullary Nailing for Femoral Fractures

Effect of Ultrasound-Guided Stellate Ganglion Block on Perioperative Inflammatory Factors in Elderly Patients Undergoing Open Reduction and Intramedullary Nailing for Femoral Fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113711
Enrollment
Unknown
Registered
2025-12-02
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral fracture

Interventions

experimental group:Perform a right-sided stellate ganglion block using 5 ml of 1% lidocaine.
Control group:Perform a right stellate ganglion block using 5ml of normal saline

Sponsors

Fengjie People's Hospital, Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 65 years; 2. ASA (American Society of Anesthesiologists) physical status classification II-III; 3. Planned elective open reduction and intramedullary nail fixation for femoral fracture; 4. Voluntarily willing to participate in this study and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe liver dysfunction (Child-Pugh class C) or renal dysfunction (chronic kidney disease stage 4-5); 2. Severe cardiovascular or pulmonary disease, such as heart failure class III-IV (NYHA classification) or severe chronic obstructive pulmonary disease; 3. Clear history of psychiatric disorders, dementia, or delirium before surgery, unable to cooperate with study assessments; 4. Known coagulation disorders (INR > 1.4, platelet count < 80 × 10^9/L) or tendency to bleed; 5. Having an immune system disease, or long-term use of glucocorticoids or immunosuppressants; 6. History of acute myocardial infarction within the past 6 months; 7. Allergic to local anesthetics used in the study (lidocaine, ropivacaine) or postoperative analgesics; 8. Infection, tumor, or anatomical abnormalities at the puncture site, making safe implementation of SGB impossible.

Design outcomes

Primary

MeasureTime frame
tumor necrosis factor;Interleukin-6;C-reactive protein;White Blood Cell Count;

Secondary

MeasureTime frame
CAM scale scoring;AIS Scale Score;VAS score;

Countries

China

Contacts

Public ContactShen Dandan

Fengjie People's Hospital, Chongqing

992048486@qq.com+86 159 2314 8436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026